In agreement with a previous meta-analysis, that was conducted on DPP-4 inhibitors including four studies on alogliptin, [27] this meta-analysis has demonstrated a significant reduction of HbA1c and ...

Learn everything you need to know about Alogliptin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

We conducted the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) trial to determine whether alogliptin is noninferior to placebo with respect to major ...

Takeda announced results from the EXAMINE study on cardiovascular safety following treatment with alogliptin in addition to standard of care in patients with type 2 diabetes (T2DM) and recent acute ...

Alogliptin is an effective add-on to glimepiride therapy for improving glycemic control in Japanese patients with Type 2 diabetes, show study findings. Furthermore, the benefits of the combination ...

Takeda Pharmaceutical Co is going to have to wait a bit longer to market alogliptin after US regulators said they need more time to evaluate the Japanese drugmaker’s experimental type 2 diabetes drug.

Please provide your email address to receive an email when new articles are posted on . AMSTERDAM — In patients with type 2 diabetes and recent ACS, major adverse CV event rates were not increased ...

Takeda Pharmaceutical Co faces a delay in getting alogliptin to market after US regulators said that they need more data to evaluate the Japanese drugmaker’s experimental type 2 diabetes drug. Takeda ...

WILMINGTON, N.C. (June 3, 2009) - PPD, Inc. (Nasdaq: PPDI) today confirmed that Takeda Pharmaceutical Company Limited has notified the European Medicines Agency, or EMEA, that it will postpone its ...

As shown in Figure 2 and 3, the pooled SMDs for alogliptin 12.5 mg treated vs controls, and alogliptin 25 mg treated vs controls demonstrated a significant reduction in HbA1c in patients treated with ...

Discover comprehensive details about Alogliptin and Pioglitazone, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The ...